Age-dependent decrease in the negative inotropic effect of carbachol on isolated human right atrium

European Journal of Pharmacology

Volumn 357, Issue 2-3, 1998, Pages 199-202

  Giessler, Christine ^a   Wangemann, Thekla ^a   Zerkowski, Hans Reinhard ^a   Brodde, Otto Erich ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Ageing, cardiac; Carbachol; Heart, human; Muscarinic M1 receptor; Muscarinic M2 receptor; Negative inotropic effect

Indexed keywords

CARBACHOL; FORSKOLIN; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; OTENZEPAD; PIRENZEPINE; PROPRANOLOL;

ADULT; AGING; ARTICLE; CHILD; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART CONTRACTION; HEART RATE; HUMAN; HUMAN TISSUE; INOTROPISM; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGING; CARBACHOL; CHILD; CHILD, PRESCHOOL; FEMALE; FORSKOLIN; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION;

EID: 0032544793     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00568-8     Document Type: Article

References (16)

1. i in human hearts with dilated but not ischemic cardiomyopathy. Circulation. 82:1990;1249-1265.
2. Bristow M.R. Changes in myocardial and vascular receptors in heart failure. J. Am. Coll. Cardiol. 22(Suppl 4):1993;61A-71A.
3. Brodde O.-E., Konschak U., Becker K., Rüter F., Poller U., Jakubetz J., Radke J., Zerkowski H.-R. Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies. J. Clin. Invest. 101:1998;471-478.
4. Brodde O.-E., Zerkowski H.-R., Schranz D., Broede-Sitz A., Michel-Reher M., Schäfer-Beisenbusch E., Piotrowski J.A., Oelert H. Age-dependent changes of the β-adrenoceptor- G-protein(s)-adenylyl cyclase system in human right atrium. J. Cardiovasc. Pharmacol. 26:1995;20-26.
5. Brodde O.-E., Hillemann S., Kunde K., Vogelsang M., Zerkowski H.-R. Receptor systems affecting force of contraction in the human heart and their alterations in chronic heart failure. J. Heart Lung Transplant. 11:1992;S164-S174.
6. Deighton N.M., Motomura S., Borquez D., Zerkowski H.-R., Doetsch N., Brodde O.-E. Muscarinic cholinoceptors in the human heart: demonstration, subclassification, and distribution. Naunyn-Schmiedeberg's Arch. Pharmacol. 341:1990;14-21.
7. Eglen R.M., Hedge S.S., Watson N. Muscarinic receptor subtypes and smooth muscle function. Pharmacol. Rev. 48:1996;531-565.
8. Furchgott, R.F., 1972. The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko, H., Muscholl, E., (Eds.), Handbook of Experimental Pharmacology, Catecholamines. Springer, Berlin, Vol. 33, pp. 283-335.
9. Giraldo E., Martos F., Gomez A., Garcia A., Vigano M.A., Ladinsky H., Sanchez de la Cuesta F. Characterization of muscarinic receptor subtypes in human tissues. Life Sci. 43:1988;1507-1515.
10. 2 cholinoceptor occupancy. Naunyn-Schmiedeberg's Arch. Pharmacol. 338:1988;207-210.
11. Poller U., Nedelka G., Radke J., Pönicke K., Brodde O.-E. Age-dependent changes in cardiac muscarinic receptor function in healthy volunteers. J. Am. Coll. Cardiol. 29:1997;187-193.
12. Roth G.S. Age changes in signal transduction and gene expression. Mech. Age. Dev. 98:1997;231-238.
13. Seamon K.B., Daly J.W. Forskolin: its biological and chemical properties. Adv. Cyclic Nucleotide Protein Phosphorylation Res. 20:1986;1-150.
14. Van Rossum J.M. Cumulative dose-response curves: II. Technique for the making of dose-response curves in isolated organs and evaluation of drug parameters. Arch. Int. Pharmacodyn. Ther. 143:1963;299-330.
15. 2 cholinoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 338:1988;19-27.
16. White M., Roden R., Minobe W., Khan M.F., Larrabee P., Wollmering M., Port D., Anderson F., Campbell D., Feldman A.M., Bristow M.R. Age-related changes in β-adrenergic neuroeffector systems in the human heart. Circulation. 90:1994;1225-1238.